US Healthcare Market Outlook 2013

The US represents the world’s largest healthcare market, with a high annual healthcare spending. The growth in healthcare spending is mainly driven by high administrative costs, and expensive hospital care. We believe that the market holds a great potential with several segments under healthcare spending still remaining untapped, indicating immense opportunities for the industry players for expanding operations. According to our report “US Healthcare Market Outlook 2013”, the US healthcare spending is expected to grow at a CAGR of around 5% during 2010-2013.

Our report covers the Hospital care, Pharmaceutical, Medical device, Healthcare IT and Healthcare Insurance segments of the industry. Among several market attractions in the US healthcare sector, M-health has been gaining increasing market penetration, and is poised for a high future growth. Due to increasing prevalence of chronic diseases and rising aging population, the healthcare facilities are in great demand leading to growth in the sector.

The pharmaceutical market is a growing segment, with several global players playing a major role. Our report gives a brief profile of these players, and emphasizes the future growth of the pharma market. It also elaborates how the latest technological advancements, which will make treatment and diagnosis simpler and effective, would impact the medical device market.

However, the country faces some severe setbacks in the industry. The research highlights the shortage of healthcare professionals which can impact the US healthcare industry in the future. It also covers how the government is striving to combat these issues.

The healthcare sector is regulated by the government, and the report covers several legislations prevailing in the industry. How the government has been trying to improve the healthcare sector performance by introducing several reforms, including The Affordable Care Act of 2010, has also been discussed along with its impact on the performance of each segment.

The report provides detailed statistical and analytical review of demographics, disease profiles, and key drivers affecting the US healthcare sector. It contains exhaustive information that will facilitate clients to draw up market strategies and assess opportunities in the US healthcare market.

E-Healthcare Industry in the United States

1. Analyst View
2. Research Methodology
3. Healthcare Market Overview
4. Market Attractions
4.1 Rising Health Concerns with Ageing Population
4.2 Increasing Prevalence of Lifestyle and Chronic Diseases
4.3 Strong Government Support
4.4 Upcoming Field of Mobile Health
5. Healthcare Service Market
5.1 Hospital Service Market
5.1.1 Hospitals and Beds
5.1.2 Inpatients and Outpatients
5.1.3 Manpower Availability
5.2 Pharmaceutical Market
5.2.1 Market Overview
5.2.2 Generics and Branded Drugs
5.2.3 OTC and Prescription Drugs
5.2.4 Distribution Channel
5.3 Medical Device Market
5.3.1 Market Overview
5.3.2 Export and Import Analysis
5.4 Healthcare IT Market
5.5 Healthcare Insurance Market
6. Regulatory Environment
6.1 Healthcare Reform 2010
6.1.1 Impact of the Reform
6.2 Pharmaceutical Market
6.3 Medical Device Market
6.4 Healthcare IT Market
7. Industry Challenges
7.1 Lack of Efficiency in Healthcare System
7.2 Pill Pushing
7.3 Geographic Variation in Healthcare
7.4 Medical Wastage
8. Industry Players by Segment
8.1 Hospitals Market
8.2 Pharmaceutical Market
8.3 Medical Devices Market
8.4 Healthcare IT Market

List of Figures:

Figure 3-1: National Healthcare Expenditure (Trillion US$), 2007-2010 & 2013
Figure 3-2: National Health Expenditure by Source of Payment (%), 2009
Figure 4-1: mHealth Market (Billion US$), 2009-2013
Figure 5-1: Hospital Care Expenditure (Billion US$), 2004, 2009 & 2014
Figure 5-2: Number of Hospitals (2006-2009)
Figure 5-3: Number of Hospital Beds (‘000), 2006-2009
Figure 5-4: Share of Hospitals in Rural Areas based on Bed Size (2009)
Figure 5-5: Share of Hospitals in Urban Areas based on Bed Size (2009)
Figure 5-6: Outpatients Visit in Hospitals (Million), 2005-2008
Figure 5-7: Pharmaceutical Market (Billion US$), 2008-2013
Figure 5-8: Prescriptions Dispensed (Billion), 2006-2010
Figure 5-9: Share of Generics and Branded Drugs in Pharmaceutical Market (2010)
Figure 5-10: Share of Generic Prescriptions in Total Prescriptions (2006-2010)
Figure 5-11: Prescription Drug Sales by Distribution Channel (%), 2010
Figure 5-12: Medical Device Market (Billion US$), 2010-2013
Figure 5-13: Medical Device Export by Region (%), 2007
Figure 5-14: Medical Device Export by Product (%), 2008
Figure 5-15: Medical Device Import by Product (%), 2008
Figure 5-16: Healthcare IT Market (Billion US$), 2010-2013
Figure 5-17: Percentage of Office-based Physicians Using EMRs/EHRs (2006-2009)
Figure 5-18: Healthcare Payment under Medicare and Medicaid Programs (Billion US$), 2008-2013
Figure 5-19: Healthcare Payment through Private Insurance (Billion US$), 2009-2013

List of Tables:

Table 4-1: Demographic Characteristics (2008-2010)
Table 4-2: Number of Deaths due to Leading Causes (2009)
Table 5-1: Number of M&A Activity in US Healthcare Services Industry (2006-2009 & H1 2010)
Table 5-2: Inpatients Statistics in Hospitals (2005-2008)
Table 5-3: Sales of Top Ten Therapies by Spending in Pharmaceutical Market (Billion US$), 2010
Table 5-4: Sales of Top Ten Products in Pharmaceutical Market (Billion US$), 2010
Table 5-5: Medical Equipment Technologies Subsectors
Table 5-6: Top Medical Device Companies by Revenue (Billion US$), 2010
Table 5-7: Potential Savings from Healthcare IT-enabled Efficiencies
Table 5-8: E-prescription Statistics (2007-2009)
Table 6-1: Affordable Care Act Timeline: Proposed Actions
Table 8-1: Sales of Top Ten Companies in Pharmaceutical Market (Billion US$), 2010